Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,163 results for ""Drug therapy""

Your Filters

Publication : plos medicine
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

  • Authors : James LP; PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Subjects: Cost-Benefit Analysis* ; Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Rifampin*/Rifampin*/Rifampin*/economics

  • Source: PLoS medicine [PLoS Med] 2024 May 03; Vol. 21 (5), pp. e1004401. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.

  • Authors : Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.

Subjects: Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Tuberculosis*/Tuberculosis*/Tuberculosis*/prevention & control ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/drug therapy

  • Source: PLoS medicine [PLoS Med] 2024 Feb 20; Vol. 21 (2), pp. e1004356. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study.

  • Authors : Powell EM; Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Gungabissoon U

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Warfarin*/Warfarin*/Warfarin*/therapeutic use

  • Source: PLoS medicine [PLoS Med] 2024 Aug 29; Vol. 21 (8), pp. e1004377. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).

  • Authors : Nguyen C; Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France.; AP-HP. Centre-Université Paris Cité, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpital Cochin, Paris, France.

Subjects: Osteoarthritis, Knee*/Osteoarthritis, Knee*/Osteoarthritis, Knee*/drug therapy ; Osteoarthritis, Knee*/Osteoarthritis, Knee*/Osteoarthritis, Knee*/complications ; Resveratrol*/Resveratrol*/Resveratrol*/administration & dosage

  • Source: PLoS medicine [PLoS Med] 2024 Aug 13; Vol. 21 (8), pp. e1004440. Date of Electronic Publication: 2024 Aug 13 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.

  • Authors : Burman W; Public Health Institute at Denver Health and the Department of Medicine, University of Colorado, Denver, Colorado, United States of America.; Rucsineanu O

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects

  • Source: PLoS medicine [PLoS Med] 2024 Jul 25; Vol. 21 (7), pp. e1004438. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.

  • Authors : Cadot S; INSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.; Laboratoire d'Excellence 'TOUCAN-2', Toulouse, France.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/pathology ; Adenine*/Adenine*/Adenine*/analogs & derivatives

  • Source: PLoS medicine [PLoS Med] 2024 Jul 22; Vol. 21 (7), pp. e1004430. Date of Electronic Publication: 2024 Jul 22 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis.

  • Authors : Yin X; Department of Management Science and Information Systems, Spears School of Business, Oklahoma State University, Tulsa, Oklahoma, United States of America.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.

Subjects: Gonorrhea*/Gonorrhea*/Gonorrhea*/drug therapy ; Gonorrhea*/Gonorrhea*/Gonorrhea*/epidemiology ; Gonorrhea*/Gonorrhea*/Gonorrhea*/economics

  • Source: PLoS medicine [PLoS Med] 2024 Jul 08; Vol. 21 (7), pp. e1004424. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study.

  • Authors : Bosch F; Department of Internal Medicine, Tergooi Hospitals, Hilversum, the Netherlands.; Amsterdam UMC location University of Amsterdam, Department of Vascular Medicine, Amsterdam, the Netherlands.

Subjects: Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/adverse effects ; Neoplasms*/Neoplasms*/Neoplasms*/mortality

  • Source: PLoS medicine [PLoS Med] 2024 Jul 01; Vol. 21 (7), pp. e1004400. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

  • Authors : Wang DS; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Ren C

Subjects: Cetuximab*/Cetuximab*/Cetuximab*/administration & dosage ; Cetuximab*/Cetuximab*/Cetuximab*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use FOLFOXIRI protocol; Folfox protocol

  • Source: PLoS medicine [PLoS Med] 2024 May 10; Vol. 21 (5), pp. e1004389. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cardiovascular outcomes 50 years after antenatal exposure to betamethasone: Follow-up of a randomised double-blind, placebo-controlled trial.

  • Authors : Walters AGB; Liggins Institute, University of Auckland, Auckland, New Zealand.; Gamble GD

Subjects: Premature Birth*/Premature Birth*/Premature Birth*/epidemiology ; Premature Birth*/Premature Birth*/Premature Birth*/prevention & control ; Premature Birth*/Premature Birth*/Premature Birth*/drug therapy

  • Source: PLoS medicine [PLoS Med] 2024 Apr 01; Vol. 21 (4), pp. e1004378. Date of Electronic Publication: 2024 Apr 01 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  1,163 results for ""Drug therapy""